Plant Health Care is a leading provider of proprietary agricultural biological products and technology solutions focused on improving crop performance.

We sell products today through our Commercial segment and also invest in R&D to invent new platforms in our New Technology segment.

The mission of Plant Health Care is to provide novel naturally based products to the global agriculture industry to help feed the world.

Information updated: 29 December 2022

Registered name: Plant Health Care PLC
Registered number: 05116780
Place of incorporation: England
Registered office: c/o DWF LLP, 1 Scott Place
2 Hardman Street
M3 3AA
Legal form of company: Public Limited Company
ISIN: GB00B01JC540

The Company’s main country of operation is the United States of America.

Visit our Reports and presentations page for our archive of reports and documentation:

View archive

For Regulatory News Service (RNS) announcements, please view our Company news archive.

Constitutional documents

Read biographies of our Board of Directors or view our Corporate Governance and committee documentation.

Details of our NOMAD, advisers and contacts can be found within our Shareholder information section.

Or you can contact our investor relations team on

Plant Health Care PLC is listed on the AIM market of the London Stock Exchange and the OTCQB Venture Market in the United States.

Currently, securities are not traded on any other exchange or trading platform.

View share price information

There are no restrictions on the transfer of the Company’s shares.

Below are details of the number of securities in issue, the number of securities held as treasury shares and, insofar as the Company is aware, the percentage of securities that is not in public hands, together with the identity and percentage holdings of significant shareholders.

Data correct as at 29 June 2023

The number of shares in issue – 341,532,957

The number of securities held as treasury shares – NIL

Percentage of shares not in public hands – 42.16% of the Company’s securities were not in public hands.

Significant shareholders

Data correct as of 29 June 2023 – being latest share analysis date except where TR-1 notification are made subsequent to that date.

The Directors are aware of the following persons who, directly or indirectly, are invested in 3% or more of the Company’s existing ordinary share capital:

Name Shares held Percentage of issued share capital*
Ospraie AG Science 58,072,79017.00
Scobie Ward 38,984,62411.41
Richard Griffiths 36,910,00010.81
Janus Henderson 33,322,3279.76
Boulder River 14,059,2034.12
Lombard Odier 13,086,8473.83
Premier Fund Managers Limited 12,661,8533.71
Hargreaves Lansdown Stockbrokers 11,123,2193.26

* The percentages shown are based on the most recent share register analysis or notification.

The Company is subject to the UK City Code on Takeovers and Mergers.